SILICON LABORATORIES INC. SLAB
Nasdaq · XNAS · stock · Semiconductors & Related Devices
Chart by TradingView
5/9
Piotroski F — financial health
11.34
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2026 | $784.8M | -$64.9M | $457.0M | $65.8M | $1.1B |
| 2024 | $584.4M | -$191.0M | $312.2M | -$25.7M | $1.1B |
| 2023 | $782.3M | -$34.5M | $460.6M | -$52.6M | $1.2B |
| 2022 | $1.0B | — | $642.6M | $114.7M | $1.4B |
| 2022 | $720.9M | — | $425.4M | $62.6M | $2.2B |
| 2021 | $510.9M | — | $294.8M | -$26.9M | $1.2B |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 11.34 (safe)
- Working capital / assets 0.418
- Retained earnings / assets 0.738
- EBIT / assets -0.056
- Equity / liabilities 6.257
Source: SEC EDGAR filings · CIK 0001038074 · as of 2026-01-03. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.